Drug competition issues Monitor drug supply chain issues
2025 · 4th Quarter (Oct 1 - Dec 31)
ASSOCIATION FOR ACCESSIBLE MEDICINES
Filed by THE GIBSON GROUP, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 16, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- THE GIBSON GROUP, LLC
- Filing UUID
- 3f6e4a46-025a-44b0-a479-78154ef0029c
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Drug competition issues
Monitor S. 1096 - patent settlements Issues relating to review of pharmaceutical patents in inter partes reviews Issues relating to the Patent Trial and Appeal Board Patent thickets - S. 1041 Monitor S. 1040 - product hopping Skinny labeling issues Monitor issues relating to the Patent Eligibility Restoration Act Monitor issues relating to the PREVAIL Act
Literal federal measure citations: S. 1096, S. 1041, S. 1040
Monitor issues related to trade agreeements
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.